Rare diseases
Investigational molecules
Locations
Study on Ustekinumab and Guselkumab for Children with Active Juvenile Psoriatic Arthritis
The NetherlandsStudy of Tucatinib and Ado-Trastuzumab Emtansine for Patients with Advanced HER2+ Breast Cancer
The NetherlandsStudy on the Safety and Tolerability of Oral Dersimelagon for Patients with Erythropoietic Protoporphyria or X-Linked Protoporphyria
The NetherlandsStudy on Long-Term Safety and Effectiveness of Ofatumumab for Patients with Relapsing Multiple Sclerosis
The NetherlandsStudy on the Effectiveness and Safety of Mitapivat for Patients with Non-Transfusion-Dependent Alpha or Beta Thalassemia
The NetherlandsStudy Comparing Datopotamab Deruxtecan and Docetaxel for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer
The NetherlandsStudy Comparing Abelacimab and Apixaban for Preventing Blood Clots in Cancer Patients
The NetherlandsStudy on Abelacimab and Dalteparin for Preventing Blood Clots in Patients with Gastrointestinal or Genitourinary Cancer
The NetherlandsStudy on the Effects of Mitapivat for Patients with Transfusion-Dependent Alpha or Beta Thalassemia
The NetherlandsStudy on Personalized Dosing of Natalizumab for Patients with Relapsing-Remitting Multiple Sclerosis
The NetherlandsLong-Term Follow-Up Study of TX200-TR101 for Patients with Kidney Transplant Rejection
The NetherlandsStudy Comparing Gilteritinib and Midostaurin with Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with FLT3 Mutation
The NetherlandsTell us about your condition – we search every trial in Europe and connect you with the right site.
